TENS and Taping for Older People

Sponsor
The University of Hong Kong (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05596110
Collaborator
(none)
24
4
12

Study Details

Study Description

Brief Summary

Aim: To examine the acute effects of transcutaneous electrical nerve stimulation (TENS) and Kinesio Taping (KT) on lower limb joint proprioception, static standing balance, limits of stability and functional balance performance in community-dwelling older adults.

Design: A one-group experimental study with a repeated-measures design. Sample: 24+ community-dwelling older adults Interventions: TENS and KT, TENS and sham taping, KT and sham TENS, and sham TENS and sham taping (30 minutes each) Major outcomes: Outcomes will be evaluated during each of the intervention conditions. Lower limb joint active repositioning error will be evaluated using a joint position sense test; a force platform will be used to assess the single-leg standing body sway path length and velocity; a functional reach test will give a score that reflects the limits of stability of the participants; and the timed up-and-go test will be used to quantify functional balance performance of the participants.

Anticipated results and significance: It is predicted that both TENS and KT, when applied together, may best improve lower limb joint proprioception and facilitate all balance performances among the community-dwelling older adults. These interventions could be applied in clinical settings to improve joint proprioception and postural control of the elderly people.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: TENS and KT
  • Behavioral: TENS and sham taping
  • Behavioral: KT and sham TENS
  • Behavioral: Sham TENS and sham taping
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
24 participants
Allocation:
Non-Randomized
Intervention Model:
Factorial Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Acute Effects of Transcutaneous Electrical Nerve Stimulation and Kinesio Taping on Lower Limb Joint Proprioception, Static Standing Balance, Limits of Stability and Functional Balance Performance in Community-dwelling Older Adults
Anticipated Study Start Date :
Dec 1, 2022
Anticipated Primary Completion Date :
Nov 30, 2023
Anticipated Study Completion Date :
Nov 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: TENS and KT

TENS will be applied on the medial and lateral joint lines of the knee and ankle joints and the anterior and posterior joint lines of the hip joint of both legs. In addition, KT will be applied to major postural muscles including the bilateral gluteus medius, quadriceps, and gastrocnemius of the participants.

Behavioral: TENS and KT
TENS will be delivered using three E704SD TIMER TENS devices (or similar) through pairs of electrodes placed on the medial and lateral joint lines of the knee and ankle joints and the anterior and posterior joint lines of the hip joint of both legs. In addition, KT (Kinesio Tex Gold) will be applied to major postural muscles including the bilateral gluteus medius (i.e., crosses hip joint), quadriceps (i.e., crosses the knee joint), and gastrocnemius (i.e., crosses ankle joint) of the participants.

Sham Comparator: TENS and sham taping

TENS will be applied on the medial and lateral joint lines of the knee and ankle joints and the anterior and posterior joint lines of the hip joint of both legs. In addition, sham tapes will be applied to major postural muscles including the bilateral gluteus medius, quadriceps, and gastrocnemius of the participants.

Behavioral: TENS and sham taping
TENS will be delivered using three E704SD TIMER TENS devices (or similar) through pairs of electrodes placed on the medial and lateral joint lines of the knee and ankle joints and the anterior and posterior joint lines of the hip joint of both legs. In addition, sham tapes will be applied to major postural muscles including the bilateral gluteus medius (i.e., crosses hip joint), quadriceps (i.e., crosses the knee joint), and gastrocnemius (i.e., crosses ankle joint) of the participants.

Sham Comparator: KT and sham TENS

KT will be applied to major postural muscles including the bilateral gluteus medius, quadriceps, and gastrocnemius of the participants. In addition, sham TENS will be applied on the medial and lateral joint lines of the knee and ankle joints and the anterior and posterior joint lines of the hip joint of both legs.

Behavioral: KT and sham TENS
KT (Kinesio Tex Gold) will be applied to major postural muscles including the bilateral gluteus medius (i.e., crosses hip joint), quadriceps (i.e., crosses the knee joint), and gastrocnemius (i.e., crosses ankle joint) of the participants. In addition, sham TENS will be applied on the medial and lateral joint lines of the knee and ankle joints and the anterior and posterior joint lines of the hip joint of both legs.

Sham Comparator: Sham TENS and sham taping

Sham TENS will be applied on the medial and lateral joint lines of the knee and ankle joints and the anterior and posterior joint lines of the hip joint of both legs. In addition, sham tapes will be applied to major postural muscles including the bilateral gluteus medius, quadriceps, and gastrocnemius of the participants.

Behavioral: Sham TENS and sham taping
Sham TENS will be applied on the medial and lateral joint lines of the knee and ankle joints and the anterior and posterior joint lines of the hip joint of both legs. In addition, sham tapes will be applied to major postural muscles including the bilateral gluteus medius (i.e., crosses hip joint), quadriceps (i.e., crosses the knee joint), and gastrocnemius (i.e., crosses ankle joint) of the participants.

Outcome Measures

Primary Outcome Measures

  1. Joint active repositioning test error (using goniometry, in degree) [Day 1 to Day 4]

    Lower limb joint proprioception test - Joint active repositioning error of the hip, knee and ankle joints of both lower limbs

Secondary Outcome Measures

  1. Center of pressure (COP) sway path length in static single-leg standing (using a force platform, in cm) [Day 1 to Day 4]

    Static single-leg standing balance performance - COP sway path length in static single-leg standing

  2. Center of pressure (COP) sway velocity in static single-leg standing (using a force platform, in m/s) [Day 1 to Day 4]

    Static single-leg standing balance performance - COP sway velocity in static single-leg standing

  3. Functional Reach Test score (using a cloth measuring tape, in cm) [Day 1 to Day 4]

    Limits of stability balance performance - Functional Reach Test score

  4. Timed Up-and-Go Test completion time (using a stop watch, in s) [Day 1 to Day 4]

    Functional balance performance - Timed Up-and-Go Test completion time

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion criteria:
  • Between 60 and 75 years old

  • Able to ambulate independently and safely without using any walking aid

  • Able to follow instructions

Exclusion criteria:
  • Known unstable medical condition (e.g., uncontrolled hypertension)

  • Known sensorimotor or neurological disorders (e.g., stroke and epilepsy)

  • Significant musculoskeletal disorder of the lower limbs (e.g., osteoarthritis of the knee)

  • Cognitive disorder

  • Presence of an implanted electrical device (e.g., cardiac pacemaker)

  • Cancer

  • A change in skin sensation

  • Wound around the lower limb joints

  • A recent injury that may affect test performance

  • Allergy to adhesive tapes

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • The University of Hong Kong

Investigators

  • Principal Investigator: Shirley SM Fong, PhD, Chinese University of Hong Kong

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Shirley S.M. Fong, Principal Investigator, Chinese University of Hong Kong
ClinicalTrials.gov Identifier:
NCT05596110
Other Study ID Numbers:
  • CU1
First Posted:
Oct 27, 2022
Last Update Posted:
Nov 7, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Nov 7, 2022